PRURIGO NODULARIS

Clinical trials for PRURIGO NODULARIS explained in plain language.

Never miss a new study

Get alerted when new PRURIGO NODULARIS trials appear

Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 6 Completed 9 Terminated 1

New drug aimed at calming the itch of prurigo nodularis enters human testing

Symptom relief Not yet recruiting

This Phase 2 study tests lebrikizumab (Ebglyss) in 15 adults with moderate-to-severe prurigo nodularis, a skin condition causing intense itching and hard bumps. Participants receive injections every two weeks for 24 weeks. The main goals are to measure how much itching decreases …

Matched conditions: PRURIGO NODULARIS

Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief

Last updated Jun 27, 2026 13:00 UTC

PRURIGO NODULARIS

Get alerted when new PRURIGO NODULARIS trials appear

New drug aimed at calming the itch of prurigo nodularis enters human testing